EFX
38
2
DOW
44
10
ADBE
49
3
HP
48
3
BF.B
33
2
AMG
54
2
DTE
56
2
TRIP
47
3
IBM
58
-2
FDX
43
3
BK
74
2
DHI
48
4
FITB
63
3
M
37
12
AN
58
4
IR
66
3
LEG
36
4
LLY
37
-3
ORCL
65
-2
MAT
46
12
EFX
38
2
DOW
44
10
ADBE
49
3
HP
48
3
BF.B
33
2
AMG
54
2
DTE
56
2
TRIP
47
3
IBM
58
-2
FDX
43
3
BK
74
2
DHI
48
4
FITB
63
3
M
37
12
AN
58
4
IR
66
3
LEG
36
4
LLY
37
-3
ORCL
65
-2
MAT
46
12
Financhill
Back

Verrica Pharmaceuticals Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
32

VRCA
Verrica Pharmaceuticals

Last Price:
1.00
Seasonality Move:
50.53%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Verrica Pharmaceuticals Price Quote

$1.00
+0.01 (+1.01%)
(Updated: November 23, 2024 at 6:00 AM ET)

Verrica Pharmaceuticals Key Stats

Sell
32
Verrica Pharmaceuticals (VRCA) is a Sell
Day range:
$0.96 - $1.02
52-week range:
$0.70 - $11.41
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
5.02
P/B ratio:
0%
Volume:
552.6K
Avg. volume:
732.9K
1-year change:
-72.75%
Market cap:
$45.4M
Revenue:
$5.1M
EPS:
$-1.84

How Much Does Verrica Pharmaceuticals Make?

Is Verrica Pharmaceuticals Growing As A Company?

Data Unavailable

Verrica Pharmaceuticals Stock Price Performance

What Is Verrica Pharmaceuticals 52-Week High & Low?

Verrica Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Verrica Pharmaceuticals?

Is Verrica Pharmaceuticals Cash Flow Positive?

  • What Is VRCA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$59.4M
  • What Is Verrica Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.7M
  • What Is Verrica Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$254K

Verrica Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    VRCA return on invested capital is -184.44%
  • What Is Verrica Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -128.78%
  • What Is VRCA Return On Equity?
    ROE is a measure of profitability and is -2619.46%

Verrica Pharmaceuticals Earnings Date & Stock Price

Verrica Pharmaceuticals Competitors

Verrica Pharmaceuticals Dividend Yield

Verrica Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -26.45%
Revenue: 0% -133.85%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 4
Sell Recommendations: 0
Price Target: 6.33
Upside from Last Price: 536.84%

Major Shareholders

  • How many VRCA shares are owned by institutional investors?
    22.3M VRCA shares are owned by institutional investors
  • How many VRCA shares are owned by insiders?
    11.7M VRCA shares are owned by insiders